Integral Diagnostics Ltd
IDX
Company Profile
Business description
Integral Diagnostics is Australia’s fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
Contact
45 William Street
Suite 9.02, Level 9
MelbourneVIC3000
AUST: +61 353390704
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
1,977
Integral Diagnostics Ltd News & Analysis
stocks
Undervalued ASX share proposes merger
We view the proposed tie up as value-dilutive but the shares remain undervalued.
stocks
Why the market may be underestimating this healthcare stock
Inexpensive healthcare stocks offering defensive earnings have become harder to find in recent months, but a new addition to Morningstar’s coverage universe may provide an opportunity.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,452.70 | 136.00 | 1.64% |
| CAC 40 | 7,260.79 | 13.69 | -0.19% |
| DAX 40 | 19,869.45 | 15.30 | -0.08% |
| Dow JONES (US) | 42,840.26 | 498.02 | 1.18% |
| FTSE 100 | 8,073.99 | 10.62 | -0.13% |
| HKSE | 19,883.13 | 162.43 | 0.82% |
| NASDAQ | 19,572.60 | 199.83 | 1.03% |
| Nikkei 225 | 39,161.34 | 459.44 | 1.19% |
| NZX 50 Index | 12,988.03 | 83.92 | 0.65% |
| S&P 500 | 5,930.85 | 63.77 | 1.09% |
| S&P/ASX 200 | 8,201.60 | 134.60 | 1.67% |
| SSE Composite Index | 3,351.26 | 16.81 | -0.50% |